|
By: Katie Gomez Big Pharma’s reign in the United States might be over with RFK Jr.’s appointment as the new National Director of the Health and Human Services Department. The traditional pharmaceutical market is experiencing significant transformation in 2025, driven by complex regulatory dynamics and evolving healthcare policies. Major pharmaceutical companies face unprecedented challenges and… Source
Category:
Investing
Category:
Investing
Category:
Investing
All news |
||||||||||||||||||
|